Focus Partners Advisor Solutions’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$4.09M	Buy	5,290 +887	+20%	+$679K	0.04%	201
2025 Q4	$3.4M	Buy	4,403 +1,494	+51%	+$1.01M	0.04%	211
2025 Q3	$1.8M	Buy	+2,909	New	+$1.64M	0.02%	365
2025 Q2	–	Sell	-849	Closed	-$538K	–	1156
2025 Q1	$538K	Buy	+849	New	+$584K	0.01%	568
2024 Q4	–	Sell	-371	Closed	-$390K	–	853
2024 Q3	$390K	Buy	371 +3	+0.8%	+$3.34K	0.01%	502
2024 Q2	$387K	Buy	368 +158	+75%	+$153K	0.01%	432
2024 Q1	$202K	Buy	+210	New	+$200K	0.01%	583
2022 Q4	–	Sell	-451	Closed	-$311K	–	412
2022 Q3	$311K	Buy	+451	New	+$284K	0.02%	299
2022 Q1	–	Sell	-342	Closed	-$216K	–	348
2021 Q4	$216K	Buy	+342	New	+$210K	0.05%	130